Last reviewed · How we verify
NCT04256889
Use Of Nfant(R) Technology Feeding System For Infants Less Than 30 Weeks GA
NA trial testing nfant(R) feeding system in Prematurity in 23 participants. Completed in 13 March 2024.
13 March 2024
Quick facts
| Lead sponsor | Woman's |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 23 |
| Start date | 15 January 2020 |
| Primary completion | 13 March 2024 |
| Estimated completion | 13 March 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- nfant(R) feeding system
Conditions studied
- Prematurity — all drugs for Prematurity →
- Extreme Prematurity — all drugs for Extreme Prematurity →
Sponsor
Woman's — full company profile →
Who can join
Adults 22 Weeks to 29 Weeks, any sex, with Prematurity or Extreme Prematurity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of the study is to utilize the objective data provided by the nfant® suite of products, along with current NICU visual assessment and cue-based feeding practices, in order to determine if feeding performance outcomes and clinical decision making for individualized feeding plans for premature infants born less than 30 weeks PMA are impacted.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04256889
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Prematurity
Currently open trials in the same condition.
- NCT06965530 — Nourishing Tomorrow: Role of Medically Tailored Groceries in Addressing Food Insecurity During Pregnancy · NA · recruiting
- NCT06420531 — Milk And Growth In Children (MAGIC) Born Very Preterm: A Randomized Trial · NA · recruiting
- NCT07183462 — Azithromycin and Ampicillin for Late PPROM · Phase 4 · recruiting
- NCT06536296 — The Impact of Music Medicine on Preterm Brain Development and Behavior · NA · recruiting
- NCT07213414 — Metagenomic & Metabolomic Study: Bifidobacterium Probiotic Effects on Gut Microbiota & SCFA in Preterm NICU Infants · EARLY_PHASE1 · active not recruiting
Other Woman's trials
Trials by the same sponsor.
- NCT06057805 — The PPCGMS Intervention After GDM Trial · NA · terminated
- NCT04873050 — Treatment to Regress to Normoglycemia in Women with a Recent History of GDM · Phase 4 · recruiting
- NCT05067075 — The CGMS in GDM Labor and Delivery Study · NA · completed
- NCT04948112 — Effectiveness of CGMS Vs. Self-monitoring Blood Glucose (SMBG) in Woman with Gestational Diabetes · NA · completed
- NCT04726085 — Ibuprofen Versus Indomethacin Following Emergent Cerclage Placement · NA · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04256889 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Woman's
- Last refreshed: 19 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04256889.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing